Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 13, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of insider share transactions and does not contain financial performance data.
Material Changes
The filing details the acquisition of Ordinary Shares by four individuals on February 9, 2006, at a price of GBP 14.79 per share through the Company's ShareReward Plan. The transactions involved both personal contributions and company matching contributions:
- Mr J S Heslop: Acquired 9 shares (personal) and 9 shares (company match).
- Mr R Bondy: Acquired 9 shares (personal) and 9 shares (company match).
- Mrs J V Younger: Acquired 9 shares (personal) and 9 shares (company match).
- Mr A P Witty: Acquired 9 shares (personal) and 9 shares (company match).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the specific share transactions described above in accordance with Disclosure Rules 3.1.4 R (1) (a) and 3.1.4 R (1) (b).
Key Facts for Investor Verification
- Transaction Date: February 9, 2006.
- Share Price: GBP 14.79 per Ordinary Share.
- Plan Details: Transactions occurred under the ShareReward Plan entered into on October 5, 2001.
- Participants: Four senior individuals (Heslop, Bondy, Younger, Witty) each acquired a total of 18 shares (9 personal, 9 matched).
- Notification Date: The company and participants were advised of this information on February 10, 2006.